MRA Associates USA LLC Increases Holdings in Vanguard Intermediate-Term Corporate Bond ETF (NASDAQ:VCIT)

Share on StockTwits

MRA Associates USA LLC grew its holdings in shares of Vanguard Intermediate-Term Corporate Bond ETF (NASDAQ:VCIT) by 7.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,684 shares of the company’s stock after buying an additional 269 shares during the period. Vanguard Intermediate-Term Corporate Bond ETF accounts for about 1.3% of MRA Associates USA LLC’s holdings, making the stock its 25th largest holding. MRA Associates USA LLC’s holdings in Vanguard Intermediate-Term Corporate Bond ETF were worth $331,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of VCIT. Creative Planning increased its position in Vanguard Intermediate-Term Corporate Bond ETF by 3.1% in the 2nd quarter. Creative Planning now owns 27,617,708 shares of the company’s stock valued at $2,481,451,000 after acquiring an additional 819,479 shares during the period. Fisher Asset Management LLC increased its position in Vanguard Intermediate-Term Corporate Bond ETF by 23.1% in the 2nd quarter. Fisher Asset Management LLC now owns 19,632,084 shares of the company’s stock valued at $1,763,943,000 after acquiring an additional 3,684,863 shares during the period. RiverFront Investment Group LLC increased its position in Vanguard Intermediate-Term Corporate Bond ETF by 6.0% in the 1st quarter. RiverFront Investment Group LLC now owns 2,246,515 shares of the company’s stock valued at $195,154,000 after acquiring an additional 127,104 shares during the period. IndexIQ Advisors LLC increased its position in Vanguard Intermediate-Term Corporate Bond ETF by 10.7% in the 1st quarter. IndexIQ Advisors LLC now owns 1,515,554 shares of the company’s stock valued at $131,657,000 after acquiring an additional 146,029 shares during the period. Finally, Envestnet Asset Management Inc. increased its position in Vanguard Intermediate-Term Corporate Bond ETF by 19.9% in the 2nd quarter. Envestnet Asset Management Inc. now owns 1,130,401 shares of the company’s stock valued at $101,567,000 after acquiring an additional 187,504 shares during the period.

VCIT stock traded up $0.27 during trading on Friday, hitting $91.81. The company had a trading volume of 325,338 shares, compared to its average volume of 2,008,919. Vanguard Intermediate-Term Corporate Bond ETF has a 1-year low of $81.95 and a 1-year high of $91.81. The firm has a 50-day moving average price of $90.16 and a 200-day moving average price of $87.60.

The business also recently declared a monthly dividend, which was paid on Tuesday, August 6th. Investors of record on Friday, August 2nd were given a $0.274 dividend. This represents a $3.29 annualized dividend and a yield of 3.58%. The ex-dividend date was Thursday, August 1st.

About Vanguard Intermediate-Term Corporate Bond ETF

Vanguard Intermediate-Term Corporate Bond ETF seeks to track the performance of the Barclays Capital U.S. 5-10 Year Corporate Bond Index, a subset of the Barclays Capital U.S. Aggregate Float Adjusted Index. The Barclays Capital U.S. 5-10 Year Corporate Bond Index measures the investment return of U.S.

Read More: What is Cost of Capital?

Want to see what other hedge funds are holding VCIT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vanguard Intermediate-Term Corporate Bond ETF (NASDAQ:VCIT).

Institutional Ownership by Quarter for Vanguard Intermediate-Term Corporate Bond ETF (NASDAQ:VCIT)

Receive News & Ratings for Vanguard Intermediate-Term Corporate Bond ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vanguard Intermediate-Term Corporate Bond ETF and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Nucor  Releases Q3 2019 Earnings Guidance
Nucor Releases Q3 2019 Earnings Guidance
Head-To-Head Review: Jerash Holdings   & Its Competitors
Head-To-Head Review: Jerash Holdings & Its Competitors
Analyzing Provectus Biopharmaceuticals  & Abbott Laboratories
Analyzing Provectus Biopharmaceuticals & Abbott Laboratories
Head to Head Comparison: Cyberark Software  vs. Red Violet
Head to Head Comparison: Cyberark Software vs. Red Violet
Ubiquiti  Cut to Hold at Zacks Investment Research
Ubiquiti Cut to Hold at Zacks Investment Research
Zacks Investment Research Lowers Stellus Capital Investment  to Sell
Zacks Investment Research Lowers Stellus Capital Investment to Sell


 
© 2006-2019 Zolmax.